Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$351,618
+$1,176 QoQ
Shares Held
971
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,439
of 3,140 holders
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. AMGN ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
This page
|
971 | $351,618 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,618 | 971 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $350,442 | 996 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $534,824 | 1,634 | Shares | Sole | 2026-02-02 | |
| 2023-09-30 | $136,798 | 509 | Shares | Sole | 2023-12-11 | |
| No filing history on record for this holder in this stock. | ||||||